Document Detail


Feasibility of using thrombin generation assay (TGA) for monitoring of haemostasis during supplementation therapy in haemophilic patients without inhibitors.
MedLine Citation:
PMID:  22639879     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Monitoring factor replacement treatment and observing concordance with clinical haemostasis is crucial in vital haemorrhages and major surgeries in haemophilic patients. We aimed to investigate the value of the thrombin generation assay (TGA) and thromboelastography (TEG) for monitoring haemostasis in haemophilic patients during factor replacement treatment. The study group consisted of 29 patients (21 haemophilia A, 8 haemophilia B). All the patients FVIII-inhibitor were negative. A total of 35 bleeding episodes and/or surgical interventions were evaluated. aPTT, FVIII/FIX activity, TEG and TGA tests were conducted before and after factor therapy during the bleeding episode or surgical prophylaxis of haemophilic patients. Correlations among these tests were evaluated and compared with clinical responses. No correlation was found among aPTT, factor activities and clinical outcome. There were also no correlation found between TEG parameters and clinical outcome. The only significant correlation found between TGA parameters and clinical outcome was the correlation between peak thrombin. In conclusion, we found superiority of TGA-peak thrombin over other traditional tests for monitoring haemostasis in haemophilic patients in this study.
Authors:
Y Ay; C Balkan; D Y Karapinar; M Akin; B Bilenoğlu; K Kavakli
Related Documents :
17449259 - Head and neck cancer, epidemiology and histological aspects - part 1: a decade's result...
22685579 - Cd6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha...
2545069 - Relationship between immunophenotype and the development of second primary neoplasms in...
11912009 - Lack of involvement of p-glycoprotein (p-gp) in pemphigus patients with poor response t...
404029 - Asynchronous development of two monoclonal proteins (igm lambda and delta 1 chains) in ...
25295879 - Clinical necr in 18f-fdg pet scans: optimization of injected activity and variable acqu...
23793009 - Ruptured plaque and large plaque burden are risks of distal embolisation during percuta...
7887529 - Bicycle trauma: a five-year experience.
22284689 - Pretreatment staging positron emission tomography/computed tomography in patients with ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-29
Journal Detail:
Title:  Haemophilia : the official journal of the World Federation of Hemophilia     Volume:  -     ISSN:  1365-2516     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9442916     Medline TA:  Haemophilia     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 Blackwell Publishing Ltd.
Affiliation:
Deparment of Hematology, Ege University Medical School, Children's Hospital, Ege Hemophilia Center, TR-35100, Bornova, Izmir, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Exogenous Nitric oxide negatively regulates the s-nitrosylation p38 Mitogen-activated Protein Kinase...
Next Document:  Dermoscopy Distinction of Eruptive Vellus Hair Cysts with Molluscum Contagiosum and Acne Lesions.